Table 2 Clinical outcomes at 1-year follow-up.
Crude population | |||
|---|---|---|---|
Overweight/obese group (n = 378) | Normal weight group (n = 139) | p value | |
Primary endpoint | 9 (2.4%) | 11 (7.9%) | 0.004 |
CD | 1 (0.3%) | 1 (0.7%) | 0.460 |
New-onset arrhythmia | 5 (1.3%) | 4 (2.9%) | 0.245 |
ACS | 3 (0.8%) | 6 (4.3%) | 0.007 |
Propensity-score matched population | |||
Overweight/obese group (n = 262) | Normal weight group (n = 131) | p value | |
Primary endpoint | 6 (2.3%) | 11 (8.4%) | 0.006 |
CD | 0 (0.0%) | 1 (0.8%) | 0.157 |
New-onset arrhythmia | 3 (1.1%) | 4 (3.1%) | 0.192 |
ACS | 3 (1.1%) | 6 (4.6%) | 0.035 |
